| 摘要 |
The invention concerns the use for preparing an antiviral composition comprising glycoproteins, of chimeric lectins selected among the type 2 RIP group, consisting of Sambucus nigra agglutinin IV, Sambucus nigra agglutinin V and Sambucus nigra protein derived from lectin.
|
